- Release Date: 31/10/23 08:09
- Summary: Quarterly Royalty Revenue Update - September 2023
- Price Sensitive: Yes
- Download Document 229.26KB
- Forums
- ASX - By Stock
- DRR
- Ann: Quarterly Royalty Revenue Update - September 2023
Ann: Quarterly Royalty Revenue Update - September 2023
Featured News
Add DRR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.77 |
Change
0.090(2.45%) |
Mkt cap ! $1.987B |
Open | High | Low | Value | Volume |
$3.67 | $3.78 | $3.63 | $7.116M | 1.904M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 30443 | $3.75 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.77 | 37311 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 28970 | 4.120 |
1 | 166 | 4.010 |
2 | 11636 | 4.000 |
4 | 62701 | 3.980 |
2 | 21842 | 3.970 |
Price($) | Vol. | No. |
---|---|---|
3.450 | 8631 | 1 |
3.500 | 259 | 2 |
3.560 | 640 | 2 |
3.570 | 17900 | 3 |
3.590 | 122588 | 3 |
Last trade - 16.10pm 24/09/2024 (20 minute delay) ? |
Featured News
DRR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online